Optiver Holding
ADPT icon

Optiver Holding’s Adaptive Biotechnologies ADPT Stock Holding History

Optiver Holding’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Buy
762
+359
+89% +$5.5K ﹤0.01% 1602
2026
Q1 		$5.59K Buy
403
+311
+338% +$4.96K ﹤0.01% 1376
2025
Q4 		$1.49K Sell
92
-1,004
-92% -$16.4K ﹤0.01% 2120
2025
Q3 		$16.4K Buy
1,096
+239
+28% +$2.91K ﹤0.01% 1037
2025
Q2 		$9.98K Buy
857
+531
+163% +$4.82K ﹤0.01% 1010
2025
Q1 		$2.42K Sell
326
-316
-49% -$2.43K ﹤0.01% 1216
2024
Q4 		$3.85K Buy
+642
New +$3.54K ﹤0.01% 890
2024
Q3 		– Sell
-1,805
Closed -$6.53K – 939
2024
Q2 		$6.53K Buy
+1,805
New +$5.73K ﹤0.01% 772

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Optiver Holding's ADPT Position: Q2 2026 in Review

Optiver Holding increased its Adaptive Biotechnologies (ADPT) stake by 89% in Q2 2026, buying an estimated $5.5K and bringing the position to 762 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Optiver Holding first reported a position in ADPT in Q2 2024 and has held it in 8 quarters since. The position peaked at $16.4K in Q3 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Optiver Holding held 762 shares of Adaptive Biotechnologies worth $16.3K as of Q2 2026.
  • Optiver Holding bought 359 Adaptive Biotechnologies shares in Q2 2026, an estimated $5.5K.
  • Adaptive Biotechnologies made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1602 holding.
  • Optiver Holding first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 8 quarters since.
  • Optiver Holding's Adaptive Biotechnologies position peaked at $16.4K in Q3 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.